The Impact of SVR on Cirrhosis and Non-Liver Complications | December 11, 2018
Date of Presentation: December 11, 2018
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cirrhosis #direct acting antiviral #interferon treatment #liver disease #sustained virologic response
Annette Hewitt and Lisa Townshend-Bulson, Family Nurse Practitioners from the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program, present on the impact of sustained virologic response (SVR) on cirrhosis and non-liver complications in both direct acting antiviral (DAA) and interferon-based treatments.
Presented by:
Annette Hewitt, Lisa Townshend-Bulson
Annette Hewitt, ANRP, FNP-BC, is a family nurse practitioner specializing in the treatment of patients with Hepatitis C. She currently practices at the Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program. She earned both a Bachelor and Master of Science in Nursing from UAA. Annette has over 20 years of experience as a nurse practitioner.
Lisa Townshend-Bulson, ANRP, FNP-BC, is the Clinical Manager for the ANTHC Liver Disease & Hepatitis Program where she practices as a nurse practitioner, participates in program management, and as a clinical investigator in liver disease research. She has been a major contributor to the Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program. She holds a Master’s Degree in Nursing/Family Nurse Practitioner and is certified as a Family Nurse Practitioner by the American Association of Nurse Practitioners. Lisa is a member of the American Association for the Study of Liver Diseases and the American Academy of Nurse Practitioners.
Resources Provided:
Date added: December 11, 2018